Search

Your search keyword '"M, Veneziano"' showing total 4 results
Start Over Author "M, Veneziano" Topic medicine.disease
4 results on '"M, Veneziano"'

1. OC30.02: Diagnostic performance of obstetric ultrasound in prenatal diagnosis of placenta accreta in women with two or more Caesarean sections (ADoPAD study)

Author

E. Viora, Giuseppe Calì, E. Fabbri, Federico Prefumo, C. Maggi, C. Kaihura, Tamara Stampalija, Tiziana Frusca, Enrico Ferrazzi, Antonella Cromi, B. Alberghetti, Irene Cetin, N. Chianchiano, Federico Mecacci, F. Labate, Anna Fichera, Patrizia Vergani, Anna Franca Cavaliere, A. Sciarrone, Tullio Ghi, C. Cavalli, M. Veneziano, Nicola Fratelli, Francesco D'Antonio, and Fabio Facchinetti

Subjects
medicine.medical_specialty, Radiological and Ultrasound Technology, Obstetrics, business.industry, Placenta accreta, Obstetrics and Gynecology, Prenatal diagnosis, General Medicine, Obstetric ultrasound, medicine.disease, Reproductive Medicine, medicine, Radiology, Nuclear Medicine and imaging, business
Published
2019
Full Text
View/download PDF

2. OC30.03: Diagnostic performance of ultrasound in prenatal diagnosis of placenta accreta in women without previous Caesarean section (ADoPAD study)

Author

E. Viora, A. Sciarrone, Anna Franca Cavaliere, Giuseppe Calì, Tiziana Frusca, Patrizia Vergani, Enrico Ferrazzi, Anna Fichera, N. Chianchiano, B. Alberghetti, Federico Mecacci, M. Veneziano, C. Cavalli, Nicola Fratelli, Francesco D'Antonio, Fabio Facchinetti, Tullio Ghi, Antonella Cromi, Irene Cetin, C. Kaihura, C. Maggi, Federico Prefumo, Tamara Stampalija, F. Labate, and E. Fabbri

Subjects
medicine.medical_specialty, Radiological and Ultrasound Technology, business.industry, Placenta accreta, Obstetrics, medicine.medical_treatment, Ultrasound, Obstetrics and Gynecology, Prenatal diagnosis, General Medicine, medicine.disease, Reproductive Medicine, Medicine, Radiology, Nuclear Medicine and imaging, Caesarean section, business
Published
2019
Full Text
View/download PDF

3. Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

Author

Cosetta Bianchi, Walter Ricciardi, S Capri, M. Veneziano, A. D’Ausilio, and M.P. Pedone

Subjects
medicine.medical_specialty, Rivaroxaban, business.industry, Cost effectiveness, Health Policy, Non valvular atrial fibrillation, Public Health, Environmental and Occupational Health, medicine.disease, Internal medicine, Emergency medicine, Cardiology, Medicine, business, Stroke, health care economics and organizations, medicine.drug
Abstract

CONCLUSIONS: Rivaroxaban is a cost-effective alternative to VKA and is cost-saving for the SSN in the treatment of NVAF patients at highest unmet medical need.

Published
2013
Full Text
View/download PDF

4. Budget Impact Analysis of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

Author

Walter Ricciardi, M. Veneziano, Cosetta Bianchi, A. D’Ausilio, M.P. Pedone, and S Capri

Subjects
medicine.medical_specialty, Rivaroxaban, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Non valvular atrial fibrillation, Budget impact, medicine.disease, Internal medicine, medicine, Cardiology, business, Stroke, medicine.drug
Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results